IP Library Granted Patent US 9,644,227
Granted Patent B2
US 9,644,227 · App. 14/376,512 · Granted May 9, 2017

Process for the enzymatic regeneration of redox cofactors

Inventors: Ortwin Ertl (Vasoldsberg, AT); Nicole Staunig (Vasoldsberg, AT); Marta Sut (Graz, AT); Bernd Mayer (Graz, AT)
Assignee: ANNIKKI GMBH
C12P19/36C12P19/02C12P33/00C12P41/002
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,644,227
App. No.
14/376,512
Granted
May 9, 2017
Kind
B2
Abstract

A process for the enzymatic regeneration of the redox cofactors NAD + /NADH and NADP + /NADPH in a one-pot reaction, wherein, as a result of at least two further enzymatically catalyzed redox reactions proceeding in the same reaction batch (product-forming reactions), one of the two redox cofactors accumulates in its reduced form and, respectively, the other one in its oxidized form, characterized in that a) in the regeneration reaction which reconverts the reduced cofactor into its original oxidized form, oxygen or a compound of general formula R 1 C(O)COOH is reduced, and b) in the regeneration reaction which reconverts the oxidized cofactor into its original reduced form, a compound of general formula R 2 CH(OH)R 3 is oxidized and wherein R 1 , R 2 and R 3 in the compounds have different meanings.

Claims (77)

1. A process for the enzymatic regeneration of the redox cofactors NAD + /NADH and/or NADP + /NADPH in a one-pot reaction, wherein, as a result of at least two further enzymatically catalyzed redox reactions proceeding in the same reaction batch (product-forming reactions), one of the two redox cofactors accumulates in its reduced form and, respectively, the other one in its oxidized form, characterized in that

a) in the regeneration reaction which reconverts the reduced cofactor into its original oxidized form, oxygen or a compound of general formula

wherein R 1 represents a linear-chain or branched (C 1 -C 4 )-alkyl group or a (C 1 -C 4 )-carboxy alkyl group, is reduced,

b) in the regeneration reaction which reconverts the oxidized cofactor into its original reduced form, a (C 4 -C 8 )-cycloalcanol or a compound of general formula

wherein R 2 and R 3 are independently selected from the group consisting of H, (C 1 -C 6 ) alkyl, wherein alkyl is linear-chain or branched, (C 1 -C 6 ) alkenyl, wherein alkenyl is linear-chain or branched and comprises one to three double bonds, aryl, C 6 -C 12 aryl, carboxyl, (C 1 -C 4 ) carboxy alkyl, cycloalkyl, or C 3 -C 8 cycloalkyl, is oxidized,

wherein the redox cofactors NAD + /NADH and/or NADP + /NADPH are enzymatically regenerated in the one-got reaction,

wherein substrate(s) for the oxidation reaction(s) involved in the formation of a product is/are provided in the reaction batch at a concentration of at least 5% (w/v).

2. A process according to claim 1 for the enzymatic regeneration of the redox cofactors NAD + /NADH and/or NADP + /NADPH in a one-pot reaction, wherein, as a result of at least two further enzymatically catalyzed redox reactions proceeding in the same reaction batch (=product-forming reactions), one of the two redox cofactors accumulates in its reduced form and, respectively, the other one in its oxidized form, characterized in that

a) during the regeneration of the oxidized cofactor, a compound of general formula

wherein R 1 represents a substituted or unsubstituted C1-C4 alkyl group, is reduced, and

b) during the regeneration of the reduced cofactor, a compound of general formula

wherein R 2 and R 3 independently of each other are selected from the group consisting of

1) —H,

2) —(C 1 -C 6 ) alkyl, wherein alkyl is linear-chain or branched,

3) —(C 1 -C 6 ) alkenyl, wherein alkenyl is linear-chain or branched,

4) -cycloalkyl,

5) C 3 -C 8 cycloalkyl,

6) -aryl,

7) C 6 -C 12 aryl,

8) —(C 1 -C 4 ) carboxy alkyl, in case that the compound of formula I is pyruvate;

is oxidized.

3. A process according to claim 1 , wherein R 2 and R 3 independently of each other are selected from the group consisting of H, (C 1 -C 6 ) alkyl, wherein alkyl is linear-chain or branched, (C 1 -C 6 ) alkenyl, wherein alkenyl is linear-chain or branched and comprises one to three double bonds, aryl, C 6 -C 12 aryl, carboxyl, or (C 1 -C 4 ) carboxy alkyl.

4. A process according to claim 1 , characterized in that oxidation reaction(s) and reduction reaction(s) take place on the same substrate (molecular backbone).

5. A process according to claim 1 , characterized in that oxidation reaction(s) and reduction reaction(s) proceed chronologically parallel.

6. A process according to claim 1 , characterized in that, in the regeneration reaction which reconverts the oxidized cofactor into its original reduced form, 2-propanol is oxidized to acetone by means of an alcohol dehydrogenase.

7. A process according to claim 1 , characterized in that, in the regeneration reaction which reconverts the reduced cofactor into its original oxidized form, pyruvate is reduced to lactate by means of a lactate dehydrogenase.

8. A process according to claim 1 , characterized in that it is used for performing at least one oxidation reaction and at least one reduction reaction, respectively, in the same reaction batch on compounds of general formula

wherein

R 4 denotes hydrogen, a methyl group, a hydroxy group or an oxo group,

R 5 denotes hydrogen, a hydroxy group, an oxo group or a methyl group,

R 6 denotes hydrogen or a hydroxy group,

R 7 denotes hydrogen, —COR 13 , wherein R 13 is a C 1 -C 4 alkyl group which is unsubstituted or substituted with a hydroxy group, or a C 1 -C 4 carboxy alkyl group which is substituted or unsubstituted,

or R 6 and R 7 together denote an oxo group,

R 8 denotes hydrogen, a methyl group, a hydroxy group or an oxo group,

R 9 denotes hydrogen, a methyl group, a hydroxy group or an oxo group,

R 10 denotes hydrogen, a methyl group or halogen,

R 11 denotes hydrogen, a methyl group, a hydroxy group, an oxo group or halogen, and

R 12 denotes hydrogen, a hydroxy group, an oxo group or a methyl group,

wherein the structural element

denotes a benzene ring or a ring comprising 6 carbon atoms and 0, 1 or 2 C—C-double bonds.

9. A process according to claim 8 , characterized in that it is used for the conversion of dehydroepiandrosterone (DHEA) of formula

into testosterone of formula

10. A process according to claim 8 , characterized in that it is used for the enzymatic epimerization of 3α,7α-dihydroxy-5β-cholanic acid (chenodeoxycholic acid) of formula

into ketolithocholic acid of formula

by oxidation,

and into the stereoisomeric hydroxy compound 3α,7β-dihydroxy-5β-cholanic acid (ursodeoxycholic acid) of formula

by subsequent reduction,

using two opposite stereospecific hydroxysteroid dehydrogenases.

11. A process according to claim 8 , characterized in that it is used for the enzymatic epimerization of 3α,7α,12α-trihydroxy-5β-cholanic acid (cholanic acid) of formula

either

A) via oxidation to obtain 3α,7α-dihydroxy-12-oxo-5β cholanic acid (12-oxo-CDC) of formula

which is further reacted to obtain 3α-hydroxy-7,12-dioxo-5β-cholanic acid (12oxo-KLC) of formula

and subsequent reduction to the stereoisomeric hydroxy compound 3α,7β-dihydroxy-12-oxo-5β-cholanic acid (12-keto-ursodeoxycholanic acid) of formula

or

B) via oxidation to obtain 3α,12α-dihydroxy-7-oxo-5β-cholanic acid of formula

followed by enzymatic oxidation to obtain 3α-hydroxy-7,12-dioxo-5β-cholanic acid(12oxo-KLC) of formula XI, and subsequent reduction to obtain the stereoisomeric hydroxy compound 3α,7β-dihydroxy-12-oxo-5β cholanic acid (12-keto-ursodeoxycholanic acid) of formula XII,

or

C) via oxidation to obtain 3α,12α-dihydroxy-7-oxo-5β-cholanic acid of formula XIII, followed by enzymatic reduction to obtain 3α,7β,12α-triydroxy-5β-cholanic acid of formula

and subsequent oxidation to obtain the stereoisomeric hydroxy compound 3α,7β-dihydroxy-12-oxo-5β-cholanic acid (12-keto-ursodeoxycholanic acid) of formula XII;

using 3 stereospecific hydroxysteroid dehydrogenases, 2 of which have opposite stereospecifity.

12. A process according to claim 8 , wherein substrate(s) for the reduction reaction(s) involved in the formation of a product is/are provided in the reaction batch at a concentration of <5% (w/v).

13. A process according to claim 8 , wherein in the compounds of formula III, R 7 is a C 1 -C 4 carboxy alkyl group which is substituted with a hydroxy group.

14. A process according to claim 1 , characterized in that it is used for the isomerization of C 5 - or C 6 -sugars.

15. A process according to claim 14 , wherein the isomerization includes reducing glucose to sorbitol and subsequently oxidizing the sorbitol to fructose.

16. A process according to claim 1 , characterized in that, on the whole, a turnover of ≧70% is achieved in the product-forming reactions.

17. A process according to claim 1 , characterized in that substrate(s) for the oxidation reaction(s) involved in the formation of a product is/are provided in the reaction batch at a concentration of at least 7% (w/v).

18. A process according to claim 1 , characterized in that substrate(s) for the oxidation reaction(s) involved in the formation of a product is/are provided in the reaction batch at a concentration of at least 9% (w/v).

19. A process according to claim 1 , characterized in that, on the whole, a turnover of ≧90% is achieved in the product-forming reactions.

20. A process according to claim 1 , wherein the redox cofactors NAD + /NADH and NADP + /NADPH are enzymatically regenerated in the one-pot reaction.

21. A process according to claim 1 , wherein in step b), a compound according to formula II is oxidized, wherein R 2 and R 3 are independently selected from the group consisting of C 6 -C 12 aryl.

22. A process for the enzymatic regeneration of the redox cofactors selected from NAD + /NADH, NADP + /NADPH or a combination thereof in a one-pot reaction, wherein, as a result of at least two further enzymatically catalyzed redox reactions proceeding in the same reaction batch (product-forming reactions), one of the two redox cofactors accumulates in its reduced form and, respectively, the other one in its oxidized form, characterized in that

a) in the regeneration reaction which reconverts the reduced cofactor into its original oxidized form, oxygen or a compound of general formula

wherein R 1 represents a linear-chain or branched (C 1 -C 4 )-alkyl group or a (C 1 -C 4 )-carboxy alkyl group, is reduced, and

b) in the regeneration reaction which reconverts the oxidized cofactor into its original reduced form, a (C 4 -C 8 )-cycloalcanol or a compound of general formula

wherein R 2 and R 3 are independently selected from the group consisting of H, (C 1 -C 6 ) alkyl, wherein alkyl is linear-chain or branched, (C 1 -C 6 ) alkenyl, wherein alkenyl is linear-chain or branched and comprises one to three double bonds, aryl, C 6 -C 12 aryl, carboxyl, (C 1 -C 4 ) carboxy alkyl, cycloalkyl, or C 3 -C 8 cycloalkyl, is oxidized;

wherein substrate(s) for the oxidation reaction(s) of the product-forming reactions is/are provided in the reaction batch at a concentration of at least 5% (w/v), and wherein substrate(s) for the reduction reaction(s) of the product-forming reactions is/are provided in the reaction batch at a concentration of less than 5% (w/v), and

wherein, as a whole, a turnover of ≧70% is achieved in the product-forming reactions.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 3, 2014
From: ERTL, ORTWIN; STAUNIG, NICOLE; SUT, MARTA; MAYER, BERND
To: ANNIKKI GMBH
Reel/Frame 033881/0825 →
Priority Claims (3)
EP 12450007 · Feb 7, 2012 · regional
WO PCT/EP2012/067781 · Sep 12, 2012 · international
AT 1284/2012 · Dec 10, 2012 · national
Continuity (1)
Related Publication 20140377798A1 · Dec 25, 2014